Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Biogen Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five increased by 8.4% to $454.70M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five shows a downward trend with a -16.6% CAGR.
Analysis
How to read this metric
An increase indicates a shift toward longer-duration assets, potentially to capture higher yields in a stable interest rate environment.
Detailed definition
This represents the fair value of available-for-sale debt securities that have maturity dates falling between one and fi...
Peer comparison
Commonly disclosed in the notes to financial statements for companies with substantial investment portfolios.
other_available_for_sale_securities_debt_maturities_afte_540252Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $870.50M | $925.30M | $868.20M | $993.70M | $1.13B | $864.00M | $694.40M | $962.20M | $1.19B | $419.50M | $454.70M |
| QoQ Change | — | +6.3% | -6.2% | +14.5% | +13.7% | -23.5% | -19.6% | +38.6% | +24.0% | -64.8% | +8.4% |
| YoY Change | — | — | — | — | +29.8% | -6.6% | -20.0% | -3.2% | +5.6% | — | — |
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five at Other Companies
Frequently Asked Questions
- What is Biogen's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five?
- Biogen (BIIB) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five of $454.70M in Q1 2026.
- What is the long-term trend for Biogen's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five?
- Over 3 years (2020 to 2025), Biogen's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five has grown at a -16.6% compound annual growth rate (CAGR), from $722.60M to $419.50M.
- What does debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five mean?
- The value of debt investments maturing between one and five years from now.